Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ELOVL5 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA532741
Description
Percent identity with other species by BLAST analysis: Human, Gorilla, Orangutan, Gibbon, Monkey, Marmoset, Turkey, Chicken (100%) Elephant, Catfish (93%).
ELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids.
Specifications
ELOVL5 | |
Polyclonal | |
Unconjugated | |
ELOVL5 | |
1110059L23Rik; 3-keto acyl-CoA synthase ELOVL5; AI747313; AU043003; dJ483K16.1; elongation of long chain fatty acids family member 5; elongation of very long chain fatty acids protein 5; elongation of very long chain fatty acids-like 5; ELOVL FA elongase 5; ELOVL family member 5, elongation of long chain fatty acids; ELOVL family member 5, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast); ELOVL family member 5, elongation of long chain fatty acids (yeast); ELOVL fatty acid elongase 5; ELOVL2; ELOVL5; Fatty acid elongase 1; hELO1; homolog of yeast long chain polyunsaturated fatty acid elongation enzyme; homolog of yeast long chain polyunsaturated fatty acid elongation enzyme 2; PRO0530; rELO1; SCA38; spinocerebellar ataxia 38; very long chain 3-ketoacyl-CoA synthase 5; Very long chain 3-oxoacyl-CoA synthase 5; very-long-chain 3-oxoacyl-CoA synthase 5 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
428646, 60481 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
1 mg/mL | |
PBS with 0.1% sodium azide | |
Q9NYP7 | |
ELOVL5 | |
Synthetic 15 amino acid peptide from N-terminus of human ELOVL5. | |
50 μg | |
Primary | |
Human, Monkey, Chicken | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction